The qualifying criteria of this session is participants must be a CEO, Founder, Co-Founder or President of a US-based, pre-series A-funded, therapeutic Biotech company.
A unique, powerful and valuable space for the candid sharing of experience between 25-30 of the sector’s emerging and innovative pre-series A Biotech executives. Like-minded Executives are joined by 2 appropriate and value-matched industry stakeholders and partners to provide expertise, experience and best practice on strategic areas of focus. Case studies will also be delivered by a number of executives who have enjoyed success or navigated key challenges in their pursuit of company growth.
Strategic topics include, but not restricted to, drug discovery / development, progressing through the clinic, market / regulatory approval, product launch / channel strategies, business resilience, fundraising, deal making / partnerships and strategic exits.
A pre-registration only, Chatham House Rule forum hosted on Zoom where all participants are active discussants.
Attendance is free, however executives must satisfy the key criteria points outlined during registration.
Co-hosted by:
Date: Thursday 24 June 2021
Timings: 1:00PM - 3:00PM EDT / 12:00 - 2:00PM CST / 10:00AM - 12.00PM PDT
Forum Outline:
Pre-event - Benchmarking survey
10mins - Participant intro's and sharing of benchmarking results
20mins - Co-host case study 1 + Q&A
10mins - Peer case study 1
10mins - Guest speaker
20mins - Co-host case study 2 + Q&A
10mins - Peer case study 2
10mins - Peer-to-peer interactive poll
30mins - General discussion
For sponsorship enquiries contact:
Tom Roberts, VP, Business Development tom@lsxleaders.com
For speaker enquiries contact:
Becky Johnson, Conference Director becky@lsxleaders.com
